My watch list
my.bionity.com  
Login  

ETH spin-off machine running at full speed

27 companies were founded in 2018, more than any year previously

08-Jan-2019

ETH Zurich

ETH spin-offs 2018 by fields.

ETH Zurich

Since 2000, 346 spin-offs have been founded at ETH Zurich.

In 2018, ETH Zurich achieved a new record high for the number of spin-offs founded: a total of 27 founding teams took the plunge into independence. While an average of 13 ETH spin-offs were founded per year from 2000 to 2010, the following decade has seen an average of 24 per year. For Detlef Günther, Vice President of Research and Corporate Relations, the successive increase in the number of new companies over the past two decades is the best evidence that internal university support programmes pay off: “I am delighted that so many talented young people are displaying the perseverance and courage required to develop their ideas to market maturity, as this ultimately also benefits the Swiss economy and society,” he says.

Digital technologies for medicine

The spin-offs cover a wide range of subjects and reflect the breadth of research at ETH Zurich. The largest proportion of new companies – 12 in 2018 – come from the field of information and communication technology. This continues a trend that emerged a few years ago. A trend is also visible in application areas: eight spin-offs from various fields are developing products for the medical sector. For example, some of the young founders are working on a new method of root canal treatment, others on an easy-to-handle and inexpensive PET scanner for the early detection of Alzheimer’s.

In the course of the digital transformation, artificial intelligence will also become increasingly important: six of the new companies are working with machine learning methods. The spin-off Scailyte is developing a software that can analyse patterns in huge volumes of data from individual cells and link them to various diseases. This could significantly improve the early detection of a whole range of diseases, such as cancer. The fact that so many of the new spin-offs are focused on the fields of medicine and data science is unsurprising, as these are two of ETH Zurich’s main focus areas.

Success on the market

The young founders possess more than simply a good idea and faith in their own abilities, as is clearly shown by a look at the balance sheets: over the last year, ETH spin-offs were able to attract more than CHF 170 million in capital. For example, the companies Climeworks, Verity Studios and Beekeeper concluded rounds of financing with over CHF 30 million, CHF 18 million and CHF 13 million respectively. Alongside these investments, acquisitions and an initial public offering (IPO) also showed the success of ETH spin-offs. The IPO of Sensirion in March 2018, for example, was a good fit for the company’s growth strategy. This was reflected in a year-on-year increase in revenue of 30 percent in the first six months.

Facts, background information, dossiers
  • financing
  • initial public offerings
More about ETH Zürich
  • News

    3D printing of silicone components

    ETH spin-off Spectroplast has developed a method to make silicone products using a 3D printer. The young company now plans to bring to market customised medical products such as hearing aids, breast prosthesis for breast cancer patients and eventually even artificial heart valves. Their ult ... more

    Smart interaction between proteins

    Very little was known till now about DNA repair by homologous recombination, which is fundamental for human health. Now an ETH research group has for the first time isolated and studied all the key proteins involved in this process, laying the foundation for investigating many diseases. Wit ... more

    Revolutionising the CRISPR method

    Researchers at ETH Zurich have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously. Everyone’s talking about CRISPR-Cas. This biotechnological method offers a relatively quick and easy way to ... more

More about Sensirion
  • Companies

    Sensirion AG

    Sensirion is the leading international supplier of digital microsensor components and systems. Its range of high-quality products includes flow meters and flow controllers for gases and liquids, differential pressure sensors as well as humidity and temperature sensors. Amongst others, Sensi ... more

More about Scailyte
  • News

    Using algorithms to track down cancer

    Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of t ... more

    Scailyte raises CHF 2.75M in seed funding

    Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75M in seed funding and gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders, thus reaffirm ... more

  • Companies

    Scailyte AG

    A new and emerging type of analytical devices are producing rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection but it requires sophisticated and innovative computationa ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE